208 related articles for article (PubMed ID: 35985703)
1. The Antiphospholipid Syndrome in the Pediatric Population.
Sloan EE; McCurdy D
Adv Pediatr; 2022 Aug; 69(1):107-121. PubMed ID: 35985703
[TBL] [Abstract][Full Text] [Related]
2. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry.
Avcin T; Cimaz R; Silverman ED; Cervera R; Gattorno M; Garay S; Berkun Y; Sztajnbok FR; Silva CA; Campos LM; Saad-Magalhaes C; Rigante D; Ravelli A; Martini A; Rozman B; Meroni PL
Pediatrics; 2008 Nov; 122(5):e1100-7. PubMed ID: 18955411
[TBL] [Abstract][Full Text] [Related]
3. Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study.
Guedon AF; Ricard L; Laurent C; De Moreuil C; Urbanski G; Deriaz S; Gerotziafas G; Elalamy I; Audemard A; Chasset F; Alamowitch S; Sellam J; Boffa JJ; Cohen A; Wahl C; Abisror N; Maillot F; Fain O; Mekinian A
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36894193
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid syndrome-mediated acute cerebrovascular diseases and long-term outcomes.
García-Grimshaw M; Posadas-Pinto DR; Jiménez-Ruiz A; Valdés-Ferrer SI; Cadena-Fernández A; Torres-Ruiz JJ; Barrientos-Guerra JD; Amancha-Gabela M; Chiquete E; Flores-Silva FD; Cantú-Brito C
Lupus; 2022 Feb; 31(2):228-237. PubMed ID: 35042376
[TBL] [Abstract][Full Text] [Related]
5. The Ped-APS Registry: the antiphospholipid syndrome in childhood.
Avcin T; Cimaz R; Rozman B;
Lupus; 2009 Sep; 18(10):894-9. PubMed ID: 19671789
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of antiphospholipid syndrome in childhood: A review.
Rumsey DG; Myones B; Massicotte P
Blood Cells Mol Dis; 2017 Sep; 67():34-40. PubMed ID: 28283251
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management.
Rosina S; Chighizola CB; Ravelli A; Cimaz R
Curr Rheumatol Rep; 2021 Jan; 23(2):10. PubMed ID: 33511497
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Antiphospholipid Syndrome.
Arachchillage DRJ; Pericleous C
Semin Thromb Hemost; 2023 Apr; 49(3):295-304. PubMed ID: 36646109
[TBL] [Abstract][Full Text] [Related]
9. Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients.
Li C; Zuo Y; Zhang S; Makris UE; Karp DR; Li Z
Chin Med J (Engl); 2022 Mar; 135(6):658-664. PubMed ID: 35143425
[TBL] [Abstract][Full Text] [Related]
10. What is known about pediatric antiphospholipid syndrome?
Meroni PL; Argolini LM; Pontikaki I
Expert Rev Hematol; 2016 Oct; 9(10):977-85. PubMed ID: 27615277
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal symptoms as the first manifestation of antiphospholipid syndrome.
Zou X; Fan Z; Zhao L; Xu W; Zhang J; Jiang Z
BMC Gastroenterol; 2021 Apr; 21(1):148. PubMed ID: 33794795
[TBL] [Abstract][Full Text] [Related]
12. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.
Amoura Z; Bader-Meunier B; Bal Dit Sollier C; Belot A; Benhamou Y; Bezanahary H; Cohen F; Costedoat-Chalumeau N; Darnige L; Drouet L; Elefant E; Harroche A; Lambert M; Martin T; Martin-Toutain I; Mathian A; Mekinian A; Pineton De Chambrun M; de Pontual L; Wahl D; Yelnik C; Zuily S;
Rev Med Interne; 2023 Sep; 44(9):495-520. PubMed ID: 37735010
[TBL] [Abstract][Full Text] [Related]
13. Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series.
Mahmud SA; Bullock DR; Correll CK; Hobday PM; Riskalla MM; Vehe RK; Binstadt BA
Pediatr Rheumatol Online J; 2022 Aug; 20(1):70. PubMed ID: 35987646
[TBL] [Abstract][Full Text] [Related]
14. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
15. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management.
Sayar Z; Moll R; Isenberg D; Cohen H
Thromb Res; 2021 Feb; 198():213-221. PubMed ID: 33485122
[TBL] [Abstract][Full Text] [Related]
17. Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review.
Cheng C; Cheng GY; Denas G; Pengo V
Blood Rev; 2021 Jul; 48():100788. PubMed ID: 33341301
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience.
Abu-Zeinah G; Oromendia C; DeSancho MT
J Thromb Thrombolysis; 2019 Aug; 48(2):233-239. PubMed ID: 30835035
[TBL] [Abstract][Full Text] [Related]
19. Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects.
Islabão AG; Trindade VC; da Mota LMH; Andrade DCO; Silva CA
Paediatr Drugs; 2022 Jan; 24(1):13-27. PubMed ID: 34904182
[TBL] [Abstract][Full Text] [Related]
20. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
